This biographical article is written like a résumé .(October 2021) |
Gustavo S. Oderich | |
---|---|
Born | Brazil |
Nationality | Brazilian |
Education | Universidade Federal do Rio Grande do Sul |
Medical career | |
Profession | surgeon |
Institutions | Memorial Hermann–Texas Medical Center, The University of Texas Health Science Center at Houston |
Sub-specialties | vascular and endovascular surgeon |
Research | fenestrated and branched stent-graft technology |
Gustavo S. Oderich is a Brazilian American vascular and endovascular surgeon who serves as a professor and chief of vascular and endovascular surgery, and is the director of the Advanced Endovascular Aortic Program at McGovern Medical School at The University of Texas Health Science Center at Houston and Memorial Hermann Health System. He previously served as chair of vascular and endovascular division at the Mayo Clinic in Rochester, Minnesota. Oderich is recognized for his work in minimally invasive endovascular surgery and research in fenestrated and branched stent-graft technology to treat complex aortic aneurysms and dissections. [1] [2] [3]
Originally from Brazil, Oderich received his medical degree, followed by a surgical residency at the Universidade Federal do Rio Grande do Sul in 1990 to 1997 in Porto Alegre, Brazil.[ citation needed ] He completed a vascular surgery research fellowship at the University of Utah in 1998, then continued his clinical residency training in general surgery at the Mayo Clinic from 1999 to 2004. Upon completing his residency program, he trained in a vascular surgery fellowship, also at the Mayo Clinic from 2005 to 2006, followed by an extended fellowship in advanced endovascular repair at the Cleveland Clinic Foundation in 2007. [4]
Oderich focuses on the open surgical, clinical evaluation and endovascular treatment of dissections, trauma, aneurysms and aortic pathology involving any segment of the aorta. He chairs the Society for Vascular Surgery Reporting Standards on endovascular repair of complex aneurysms, which oversees several research trials. From 2007 to 2020, Oderich served as the immediate past Chair of the Vascular and Endovascular Surgery at the Mayo Clinic and was director of the Mayo Clinic Aortic Center program. The center developed research in endovascular repair of dissections and aortic aneurysms using such devices, with a significant reduction in mortality and morbidity compared to results of open surgical repair. In July, 2020, he joined The University of Texas Health Science Center, Houston. [5] [6]
Oderich serves as the global principal investigator for the Thoraco Plus trials, Cook Group Zenith Plus, and Chairs the Society for Vascular Surgery Reporting Standards. He is a nominated surgeons in the US, to have physician sponsored, Federal Drug Administration (FDA) approved access for manufacturing branched stent-grafts and Cook fenestrated to treat thoracoabdominal, aortic arch, and complex abdominal aortic aneurysms. Oderich is also specialized and involved in the sponsored device trials including the Gore TAMBE (ThoracoAbdominal Multi-Branch Endoprosthesis). Oderich also provided his research and expertise in the initial development of physician-modified endovascular grafts (PMEGs). [7] [8] Oderich is also the editor of the “Endovascular Aortic Repair: Current Techniques of fenestrated, branched and parallel grafts". Oderich serves as an Associate Editor of the Annals of Vascular Surgery and of the Journal of Cardiovascular Surgery. He is an ad hoc member or full member of the editorial board of 62 surgical and medical journals. Dr. Oderich has given over 690 Lectures and has also lectured as Invited Professor in 30 academic institutions including Harvard, UCLA, Stanford, McGill University (Montreal, Quebec Canada), Federal Drug Administration, University of Bologna (Bologna, Italy), Guy's Hospital (London, UK), King's College and Nuremberg (Nuremberg, Germany), the Universities of Paris, (Paris, France) and Munich (Munich, Germany). [9] [10] [11] [12]
{{cite book}}
: CS1 maint: location missing publisher (link){{cite book}}
: CS1 maint: location missing publisher (link)Aortic dissection (AD) occurs when an injury to the innermost layer of the aorta allows blood to flow between the layers of the aortic wall, forcing the layers apart. In most cases, this is associated with a sudden onset of severe chest or back pain, often described as "tearing" in character. Also, vomiting, sweating, and lightheadedness may occur. Other symptoms may result from decreased blood supply to other organs, such as stroke, lower extremity ischemia, or mesenteric ischemia. Aortic dissection can quickly lead to death from insufficient blood flow to the heart or complete rupture of the aorta.
An aneurysm is an outward bulging, likened to a bubble or balloon, caused by a localized, abnormal, weak spot on a blood vessel wall. Aneurysms may be a result of a hereditary condition or an acquired disease. Aneurysms can also be a nidus for clot formation (thrombosis) and embolization. As an aneurysm increases in size, the risk of rupture, which leads to uncontrolled bleeding, increases. Although they may occur in any blood vessel, particularly lethal examples include aneurysms of the Circle of Willis in the brain, aortic aneurysms affecting the thoracic aorta, and abdominal aortic aneurysms. Aneurysms can arise in the heart itself following a heart attack, including both ventricular and atrial septal aneurysms. There are congenital atrial septal aneurysms, a rare heart defect.
Interventional radiology (IR) is a medical specialty that performs various minimally-invasive procedures using medical imaging guidance, such as x-ray fluoroscopy, computed tomography, magnetic resonance imaging, or ultrasound. IR performs both diagnostic and therapeutic procedures through very small incisions or body orifices. Diagnostic IR procedures are those intended to help make a diagnosis or guide further medical treatment, and include image-guided biopsy of a tumor or injection of an imaging contrast agent into a hollow structure, such as a blood vessel or a duct. By contrast, therapeutic IR procedures provide direct treatment—they include catheter-based medicine delivery, medical device placement, and angioplasty of narrowed structures.
Vascular surgery is a surgical subspecialty in which vascular diseases involving the arteries, veins, or lymphatic vessels, are managed by medical therapy, minimally-invasive catheter procedures and surgical reconstruction. The specialty evolved from general and cardiovascular surgery where it refined the management of just the vessels, no longer treating the heart or other organs. Modern vascular surgery includes open surgery techniques, endovascular techniques and medical management of vascular diseases - unlike the parent specialities. The vascular surgeon is trained in the diagnosis and management of diseases affecting all parts of the vascular system excluding the coronaries and intracranial vasculature. Vascular surgeons also are called to assist other physicians to carry out surgery near vessels, or to salvage vascular injuries that include hemorrhage control, dissection, occlusion or simply for safe exposure of vascular structures.
An aortic aneurysm is an enlargement (dilatation) of the aorta to greater than 1.5 times normal size. They usually cause no symptoms except when ruptured. Occasionally, there may be abdominal, back, or leg pain. The prevalence of abdominal aortic aneurysm ("AAA") has been reported to range from 2 to 12% and is found in about 8% of men more than 65 years of age. The mortality rate attributable to AAA is about 15,000 per year in the United States and 6,000 to 8,000 per year in the United Kingdom and Ireland. Between 2001 and 2006, there were approximately 230,000 AAA surgical repairs performed on Medicare patients in the United States.
Abdominal aortic aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than normal. An AAA usually causes no symptoms, except during rupture. Occasionally, abdominal, back, or leg pain may occur. Large aneurysms can sometimes be felt by pushing on the abdomen. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death.
A thoracic aortic aneurysm is an aortic aneurysm that presents primarily in the thorax.
A pseudoaneurysm, also known as a false aneurysm, is a locally contained hematoma outside an artery or the heart due to damage to the vessel wall. The injury passes through all three layers of the arterial wall, causing a leak, which is contained by a new, weak "wall" formed by the products of the clotting cascade. A pseudoaneurysm does not contain any layer of the vessel wall.
Endovascular aneurysm repair (EVAR) is a type of minimally-invasive endovascular surgery used to treat pathology of the aorta, most commonly an abdominal aortic aneurysm (AAA). When used to treat thoracic aortic disease, the procedure is then specifically termed TEVAR for "thoracic endovascular aortic/aneurysm repair." EVAR involves the placement of an expandable stent graft within the aorta to treat aortic disease without operating directly on the aorta. In 2003, EVAR surpassed open aortic surgery as the most common technique for repair of AAA, and in 2010, EVAR accounted for 78% of all intact AAA repair in the United States.
Michael L. Marin is an American vascular surgeon. Together with Drs. Frank Veith, Juan C. Parodi and Claudio J. Schonholz, he was the first in the United States to perform minimally invasive aortic aneurysm surgery. In 2004, he was the first doctor to implant an intravascular telemetric monitor -- a device that alerts to physicians any leakage in aortic stent-grafts.
Randall Bertram Griepp was an American cardiothoracic surgeon who collaborated with Norman Shumway in the development of the first successful heart transplant procedures in the U.S. He had an international reputation for contributions to the surgical treatment of aortic aneurysms and aortic dissection and in heart and lung transplantations. He received nearly $8 million in grants from the National Heart, Lung, and Blood Institute.
Peter Lin is an American vascular surgeon, medical researcher, specializing in minimally invasive endovascular treatment of vascular disease. He has published extensively in the area of vascular surgery and endovascular surgery.
Kenneth Ouriel is a vascular surgeon and medical researcher. In 2007, Ouriel was appointed the chief executive officer of Sheikh Khalifa Medical City in Abu Dhabi. In 2009, he was senior vice president and chief of international operations at NewYork-Presbyterian Hospital. He has been described as one of America's top vascular surgeons.
Open aortic surgery (OAS), also known as open aortic repair (OAR), describes a technique whereby an abdominal, thoracic or retroperitoneal surgical incision is used to visualize and control the aorta for purposes of treatment, usually by the replacement of the affected segment with a prosthetic graft. OAS is used to treat aneurysms of the abdominal and thoracic aorta, aortic dissection, acute aortic syndrome, and aortic ruptures. Aortobifemoral bypass is also used to treat atherosclerotic disease of the abdominal aorta below the level of the renal arteries. In 2003, OAS was surpassed by endovascular aneurysm repair (EVAR) as the most common technique for repairing abdominal aortic aneurysms in the United States.
Frank J. Veith is an American vascular surgeon who serves as Professor of Surgery, New York University Medical Center NY, NY and Professor of Surgery Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH. He was the first vascular surgeon in the United States to perform minimally invasive aortic aneurysm surgery together with Drs. Michael L. Marin, Juan C. Parodi and Claudio J. Schonholz.
Juan Carlos Parodi is an Argentinian vascular surgeon who introduced the minimally invasive endovascular aneurysm repair (EVAR) to the world and performed the first successful endovascular repair of an abdominal aortic aneurysm on 7 September 1990 in Buenos Aires. In 1992 he was the first in the United States to perform minimally invasive aortic aneurysm surgery together with Drs. Frank Veith, Michael L. Marin and Claudio J. Schonholz. He continues to develop new techniques, including seat belt and air bag technique for cerebral protection during carotid stenting. He is recognized as a renowned pioneer in the specialty of endovascular repairs of the aorta.
Nicolai Leontievich Volodos, was a Soviet/Ukrainian cardiovascular surgeon and scientist. An innovator, Volodos developed and introduced into clinical practice the world's first endovascular stent graft for the treatment of stenotic and aneurysmal diseases of arterial system. Volodos was described by his colleagues as ”a pioneer innovator and a giant in vascular and endovascular surgery” and ”a giant of historic proportions in the vascular and endovascular specialties, and the father of endovascular grafting”.
Hazim J. Safi, MD, FACS, is a physician and surgeon who is well known for his research in the surgical treatment of aortic disease. Safi and his colleagues at Baylor College of Medicine were the first to identify variables associated with early death and postoperative complications in patients undergoing thoracoabdominal aortic operations. Safi now serves as professor of cardiothoracic surgery, and founding chair at McGovern Medical School at The University of Texas Health Science Center in Houston, TX.
Benjamin Starnes is a vascular surgeon and medical researcher. He holds the Alexander Whitehill Clowes Endowed Chair in Vascular surgery at the University of Washington. He served as a U.S. Army surgeon for 15 years, doing three tours of duty, including in the last M.A.S.H. unit. On the day of the September 11 attacks he was at the Pentagon rendering medical aid to victims, and his experience was later recounted in the book American Phoenix: Heroes of the Pentagon on 9/11. He is among the primary authors of the official guidelines for diagnosis and management of aortic disease adopted by the American College of Cardiology and the American Heart Association.
Joseph E. Bavaria, M.D., FACS, FRCS (Edin) ad hom, is an American cardiothoracic surgeon a professor of surgery at the University of Pennsylvania and Director of its Thoracic Aortic Surgery Program. Bavaria is known as a leading figure in clinical trials for catheter-based aortic valve replacement (TAVR), thoracic aortic surgery, and aortic endograft procedures (TEVAR). He wrote more than 600 research papers and founded the Penn Aortic Center. Bavaria served as the 52nd president of the Society of Thoracic Surgeons (STS) from 2016 to 2017, the 3rd President of the Thoracic Surgery Foundation (TSF) (2019-2022), the Chairman of The Society of Thoracic Surgeons/ACC TVT Registry Steering Committee (2017-2020) and an International Councilor of the European Association for Cardio-Thoracic Surgery (EACTS) (2021-2024) Bavaria has performed more than 9,000 surgeries throughout his career as of 2019.
{{cite web}}
: CS1 maint: multiple names: authors list (link)